在急性冠状动脉综合征 (ACS) 患者中Sirt6的动态变化和临床价值
1Seven Department of Cardiology, TEDA International Cardiovascular Hospital, Tianjin 300457, China. xy73617782sha@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|March 2, 2024
概括
在急性冠状动脉综合征 (ACS) 患者中,Sirtuin 6 (Sirt6) 蛋白和mRNA水平较低. 炎症性细胞因子 (IL-1β,IL-18,TnI,CK-MB,NT-proBNP) 的升高与ACS的发展有关.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生化学
背景情况:
- 急性冠状动脉综合征 (ACS) 是一种严重的心血管疾病.
- 素6 (Sirt6) 和特定的炎症性细胞因子在ACS病变发生中的作用需要进一步阐明.
- 了解这些分子参与者对于开发向疗法至关重要.
研究的目的:
- 研究 ACS.患者中Sirt6表达和炎症性细胞因子水平之间的关联.
- 确定Sirt6作为防止ACS发展的保护因素的潜在作用.
- 探索关键炎症标志物对ACS进展的贡献.
主要方法:
- 对30名患者的回顾性分析 (15名ACS,15名非ACS对照).
- 使用西式涂抹和实时PCR评估的Sirt6蛋白和mRNA水平.
- 通过ELISA和免疫光测量的炎症性细胞因子 (IL-1β,IL-18,TNI,CK-MB,NT-proBNP).
主要成果:
- 与对照组相比,ACS组中观察到明显较低的Sirt6蛋白和mRNA表达.
- 在ACS患者中显著增加IL-1β,IL-18,TnI,CK-MB和NT-proBNP的水平.
- 建议Sirt6水平和炎症标志物之间存在逆相关性.
结论:
- Sirt6可能在预防或抑制ACS的发展方面发挥保护作用.
- 炎症性细胞因子 (IL-1β,IL-18,TNI,CK-MB,NT-proBNP) 的升高似乎加速了ACS的进展.
- 研究结果强调Sirt6和炎症性细胞因子是ACS的潜在生物标志物和治疗点.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.1K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
153
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
153
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
91
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
91